Our translational research strives to bridge the bench-to-bedside gap, combining our basic and clinical strengths, to develop new therapeutics, drug delivery systems and diagnostic tools for vascular-based pathology.
Endocrine/thyroid cancer translational research (role of BRAFV600E in the angiogenic microenvironment and metabolism)
Carmelo Nucera, MD, PhD
Inflammation, vascular leakage, mitochondria, sepsis, and kidney injury
Samir M. Parikh, M.D.